Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
SynopsisP

HIV screening

Sally Murray and Erica Weir
CMAJ September 27, 2005 173 (7) 752; DOI: https://doi.org/10.1503/cmaj.050992
Sally Murray
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erica Weir
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

Background and epidemiology: At the end of 2002 an estimated 56 000 people in Canada had HIV infection or AIDS.1 Some 2800– 5150 of these people were infected during 2002. The new infections resulted predominantly from men having sex with men (40%), intravenous drug use (34%) and heterosexual encounters (21%). Canadian populations experiencing a growing incidence of HIV infection include women, Aboriginal people and people from countries where HIV is endemic.1 An estimated 17 000 (30%) of the prevalent cases involve people who have not been tested and are unaware of their infection. Screening for HIV infection therefore continues to be a public health priority.1

The US Preventive Services Task Force strongly recommends that clinicians screen all at- risk adolescents and adults. The task force recently updated their HIV screening recommendations (Box 1) and supporting scientific evidence.2 The greatest change from the previous set of recommendations is to expand HIV screening to all pregnant women and not just those who are at high risk.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Box 1.

The US task force did not make a recommendation for or against routine HIV screening for adolescents or adults who are not considered to be at risk. Although screening may detect HIV in additional persons who may benefit from treatment, the yield is low and potential harms from screening (e.g., anxiety) are evident.2

The 1998 Canadian STD Guidelines,3 which are currently being updated, include 2 additional risk factors for HIV infection: anal intercourse (receptive contact in particular) and a history of hepatitis B infection. These guidelines suggest that HIV testing should be offered to people with at-risk behaviours, patients with clinical or laboratory clues suggestive of HIV infection, anybody requesting the test and all pregnant women. Children born to mothers who have tested positive for HIV must also be evaluated.3

Clinical management: Whenever HIV screening is conducted, counselling before and after testing should also be provided. All Canadian provinces and territories make non-nominal testing available (i.e., the person ordering the test knows the patient's identity, but uses a code to order it) and nearly all provide nominal or anonymous testing options. The standard test for HIV infection, the repeatedly reactive enzyme immunoassay followed by a confirmatory Western blot or immunofluorescent antibody assay, is very accurate (sensitivity and specificity both ≥ 99%). Rapid HIV testing is also accurate (sensitivity 96%– 100%, specificity > 99.9%),2 but it is not available everywhere in Canada.

Highly active antiretroviral therapy (HAART) with 3 or more antiretroviral agents has been effective in reducing clinical progression and mortality in people with CD4 cell counts lower than 0.200 х 109/L. There is also good support for the use of antibiotics to prevent opportunistic infections.

Prevention: Condom use can prevent sexual transmission of HIV, and needle exchange programs can make intravenous drug use safer. After a suspected unprotected contact (e.g., an occupational exposure or a sexual assault), prompt prophylactic administration of antiretroviral drugs can greatly reduce the risk of HIV transmission.

In seropositive pregnant women, HAART should be started at 14–34 weeks' gestation and continued until delivery by (elective) cesarean section. The therapy regimen should be augmented with 6 weeks of neonatal prophylaxis with zidovudine, and the infant fed formula. In combination, these steps can reduce the risk of vertical transmission from some 14%– 25% to 1%– 2%.2

References

  1. 1.↵
    Public Health Agency of Canada. HIV and retrovirology laboratories. Available: www.phac-aspc.gc.ca/hast-vsmt (accessed 2005 Aug 25).
  2. 2.↵
    US Preventive Services Task Force. Screening for HIV: recommendation statement. Ann Intern Med 2005;143:32-7. Summary available: www.ahrq.gov/clinic/uspstfix.htm (accessed 2005 Aug 30).
    OpenUrlCrossRefPubMed
  3. 3.↵
    Canadian STD guidelines. Ottawa: Health Canada; 1998. Available: www.phac-aspc.gc.ca/publicat/std-mts98/ (accessed 2005 Aug 30).
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 173 (7)
CMAJ
Vol. 173, Issue 7
27 Sep 2005
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
HIV screening
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
HIV screening
Sally Murray, Erica Weir
CMAJ Sep 2005, 173 (7) 752; DOI: 10.1503/cmaj.050992

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
HIV screening
Sally Murray, Erica Weir
CMAJ Sep 2005, 173 (7) 752; DOI: 10.1503/cmaj.050992
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Applying the 2005 Canadian Hypertension Education Program recommendations: 4. Managing uncomplicated hypertension
  • A newborn requiring selective bronchial intubation
  • Does β-blocker prophylaxis improve survival after major noncardiac surgery?
Show more Synopsis

Similar Articles

Collections

  • Topics
    • HIV & AIDS

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire